Overview
- A peer‑reviewed paper published Monday reported that a transient modified mRNA encoding Myc and Cyclin T1 increased the amount of blood pumped per beat by about 10% in mice after myocardial injury.
- Researchers injected the mRNA directly into injured mouse hearts to produce short‑lived Myc and Cyclin T1 protein expression that reactivated heart muscle cells to divide and repair tissue.
- Measured by echocardiogram, functional gains persisted at 28 days and at 12 weeks in the treated animals, and the team observed no adverse effects in the mouse experiments.
- The study has won British Heart Foundation funding and the researchers plan to refine the formulation and carry out larger‑animal preclinical studies before any human trials.
- Major hurdles remain for translation to people, including testing for cancer risk or arrhythmia, finding safe delivery and dosing in bigger hearts, and determining whether the mouse-level improvement will produce meaningful patient benefits.